← Home

Weight Management

30 articles

Medicare's $50 Weight-Loss Drug Program Launches This Week: What Older Adults Need to Know

Medicare's new $50/month weight-loss drug program launches July 1, offering GLP-1 medications to 3.8 million eligible seniors, but doctors urge caution on.

Weight ManagementJun 29, 2026

The Muscle Loss Problem Pharmacists Aren't Discussing With GLP-1 Patients

GLP-1 drugs like semaglutide cause up to 45% muscle loss with weight, but protein targets and resistance training can largely prevent it.

Weight ManagementJun 25, 2026

Intermittent Fasting May Help Chronic Dieters Lose Weight Without Constant Food Monitoring

Intermittent fasting matches calorie counting for weight loss but offers a key bonus: people think about food far less, new research finds.

Weight ManagementJun 17, 2026

The Secret to Weight Loss Success With Zepbound? Setting a Goal First

Setting a weight loss goal before starting Zepbound led to significantly better results, a study of 81,000 people found.

Weight ManagementJun 16, 2026

A New Weight-Loss Drug Shows 30% Body Weight Loss in Trials. Here's What Sets Retatrutide Apart

Retatrutide, a new weight-loss drug, helped trial participants lose 30% of their body weight, surpassing Ozempic and matching bariatric surgery results.

Weight ManagementJun 14, 2026

Weight Loss Drugs Help You Shed Pounds, But They're Making You Move Less

People taking Ozempic and Wegovy are walking 560 fewer steps daily after starting treatment, and experts say exercise must be part of any weight loss drug.

Weight ManagementJun 10, 2026

Beyond Weight Loss: How GLP-1 Drugs Are Treating Sleep Apnea and Other Hidden Health Problems

GLP-1 drugs like Zepbound now treat sleep apnea by targeting weight loss, with patients reducing breathing interruptions by up to 50%.

Doctors Push Back Against Insurance Barriers to Weight-Loss Medications

The American Medical Association adopts new policies to eliminate insurance barriers blocking patient access to weight-loss drugs like Ozempic.

Menopause Makes Weight Loss Harder,But New Research Shows This Medication Works at Every Stage

New oral medication helps menopausal women lose up to 30 pounds in 72 weeks, with consistent weight loss results across all menopause stages.

A Dual-Action Weight Loss Drug Tackles Obesity and Liver Fat in New Study

New dual-action weight loss drug survodutide helped people lose 12% body weight while clearing dangerous liver fat in 84% of users.

Most Weight Lost on Wegovy and Mounjaro Is Fat, Not Muscle, New Research Shows

Around 84% of weight lost on Wegovy and Mounjaro is fat, not muscle, new research shows, with functional strength remaining intact throughout.

15% of GLP-1 Users Are Microdosing. Here's What Doctors Actually Think

About 15% of GLP-1 users are microdosing to cut costs and reduce side effects, but doctors warn there's no safety data on this approach.

A New Pill Burns Fat Without Suppressing Appetite: What Sets It Apart From Ozempic

Researchers created an experimental fat-burning pill that preserves muscle mass unlike Ozempic, targeting metabolism directly in early trials.

You Could Be Clinically Obese With a Normal BMI. Here's What That Means.

New research reveals 26% of people with normal BMI actually meet clinical obesity criteria, suggesting millions miss needed health screenings.

Weight ManagementMay 28, 2026

Scientists Discover Fat Cells Have a Hidden Second Job That Changes Everything About Obesity

Scientists discover fat cells have a dual role beyond energy storage, potentially revolutionizing obesity treatment by focusing on cell health.

Weight ManagementMay 28, 2026

The Silent Liver Disease Affecting 250 Million People Now Has a Treatment Option

Semaglutide shows promise treating MASH, a silent liver disease affecting 250 million people, by reducing inflammation and reversing scarring.

Weight ManagementMay 27, 2026

The Dose That Works: How Lower Tirzepatide Doses Keep Weight Off Long-Term

Lower tirzepatide doses maintain weight loss long-term, with 5mg keeping off 16.6% body weight vs 9.9% for those who stopped treatment entirely.

Weight ManagementMay 13, 2026

Oral Wegovy Shows Promise for Weight Loss and Mobility: What the Latest Trial Data Reveals

Oral Wegovy delivers 21.6% weight loss in early responders and improves mobility in 77% of users with poor physical function, new trial data shows.

Weight ManagementMay 11, 2026

The Nutrition Gap Nobody Talks About: Why What You Eat on GLP-1 Drugs Matters More Than Ever

GLP-1 weight loss medications reduce calorie intake by up to 39%, creating dangerous nutritional gaps.

GLP-1 Drugs Don't Ruin Surgery Results: Why Doctors Now Combine Both Treatments

New research shows GLP-1 medications don't compromise bariatric surgery effectiveness.

Beyond Weight Loss: How GLP-1 Drugs Are Reshaping Mental Health, Restaurant Menus, and Daily Life

GLP-1 weight loss drugs like Ozempic and Wegovy are linked to 42% fewer psychiatric hospital visits and 44% lower depression risk, while one in eight Americans...

FDA Moves to Block Compounded Weight Loss Drugs, Reshaping Access for Millions

The FDA has proposed excluding semaglutide and tirzepatide from compounding pharmacy lists, citing no clinical need.

Weight ManagementApr 23, 2026

Why Doctors Are Rethinking Blood Sugar Targets for Type 2 Diabetes

New guidelines suggest looser blood sugar control may benefit most patients. Here's why experts are shifting away from aggressive targets and what it means for...

Weight ManagementApr 16, 2026

The Hair Loss Side Effect Nobody Talks About When Losing Weight Fast

Rapid weight loss triggers temporary hair shedding in many people through a condition called telogen effluvium.

Weight ManagementApr 16, 2026

The GLP-1 Paradox: How Weight Loss Drugs Are Reshaping Our Culture While Raising Questions About Long-Term Solutions

GLP-1 drugs like Ozempic and Wegovy are transforming weight management, but experts warn they may mask deeper societal issues around obesity while long-term...

Weight ManagementApr 13, 2026

The Knowledge Gap: Why Millions Are Using Weight Loss Drugs Without Medical Supervision

A new study reveals that 11.7% of people are using weight loss medications without doctor oversight, often relying on social media for guidance.

Weight ManagementApr 11, 2026

When You Eat Matters as Much as What You Eat: New Study Links Meal Timing to Weight Management

A 5-year study of over 3,000 adults found that eating breakfast early and extending overnight fasts were linked to lower BMI, suggesting meal timing aligns...

Weight ManagementApr 10, 2026

Pill vs. Injection: Why Eli Lilly's New Weight Loss Pill Doesn't Match Its Injectable Competitor

Foundayo, Eli Lilly's new daily weight loss pill, loses to Zepbound injections in clinical trials.

Obesity Is Now the Second Leading Preventable Cause of Cancer. Here's What That Means for You

Excess body weight causes 1 in 10 new cancers in the U.S., ranking second only to smoking.

Your Genes May Predict How Well GLP-1 Drugs Work for You. Here's What Scientists Found.

A major study of nearly 28,000 people reveals genetic variants that predict weight loss success and side effects from GLP-1 medications like Ozempic and...